ℹ️
🇬🇧
Search
Search for publications relevant for "nonrelapse mortality"
nonrelapse mortality
Publication
Class
Person
Publication
Programmes
Export current view
publication
Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study
2024 |
Second Faculty of Medicine
publication
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
2020 |
Publication without faculty affiliation
publication
Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment
2015 |
Faculty of Medicine in Pilsen
publication
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation
2014 |
Faculty of Medicine in Pilsen
publication
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
2011 |
Central Library of Charles University
publication
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
2014 |
Publication without faculty affiliation
publication
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study
2020 |
Second Faculty of Medicine
publication
Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes
2018 |
Second Faculty of Medicine
publication
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion
2018 |
Publication without faculty affiliation
publication
Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
2019 |
First Faculty of Medicine
publication
Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial
2012 |
Faculty of Medicine in Hradec Králové
publication
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
2012 |
Central Library of Charles University
publication
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
2017 |
Third Faculty of Medicine
publication
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma
2018 |
Faculty of Medicine in Hradec Králové
publication
Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
2015 |
Publication without faculty affiliation
publication
Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation
2017 |
Second Faculty of Medicine
publication
Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome
2019 |
Faculty of Medicine in Pilsen
publication
Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission
2018 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study
2019 |
Second Faculty of Medicine